Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-02-28
1998-08-18
Peselev, Elli
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 54, 514 62, 530350, 530359, 536 551, 536 552, A01N 3718, A61K 3170
Patent
active
057958602
ABSTRACT:
Disclosed are (1) methods for identifying natural and synthetic sequences having binding specificity for glycan-binding proteins, including proteins that act as effectors of biological activity, (2) compositions and methods of producing protein-specific glycosaminoglycan sequence and ligand antagonists capable of modulating the effector function of these ligands, and therapeutic compositions comprising these antagonists; and 3) compositions and methods for producing protein-specific glycosaminoglycan sequence analogs useful as agonists, and therapeutic compositions comprising these agonists.
REFERENCES:
patent: 4826827 (1989-05-01), Lormeau et al.
patent: 5079228 (1992-01-01), Cohen et al.
patent: 5084564 (1992-01-01), Vila et al.
patent: 5112946 (1992-05-01), Maione
patent: 5116483 (1992-05-01), Lander
patent: 5158940 (1992-10-01), Larocca et al.
patent: 5164295 (1992-11-01), Kisilevsky et al.
patent: 5262403 (1993-11-01), Nicholson et al.
patent: 5380716 (1995-01-01), Conrad et al.
Lee et al., Proc. Natl. Acad. Sci. USA 88:2768-277 (1991) Analysis of Affinity & structural selectivity . . . electrophoretic approach.
Rot, Cytokine, 4(5) 347-352 (1992) "Binding of Neutrophil Attractant/Activation . . . Derman Cells".
Tanaka et al., Nature 361:79-82 (1993) "T-Cell Adhesion Induced by proteoglycan-immobilized . . . MIP-1B".
Turnbull et al., Journal of Bio. Chem. 267(15):10337-10341 (1992) "Identification of the Basic Fibroblast . . . Sulfate".
Habuchi et al. Biochem. J. 285:805-813 (1992) "Structure of a Heparan Sulphate Oligosaccharide . . . Fibroblast Growth Factor".
Plate et al., Nature 359:845-848 (1992) "Vascular Endothelial Growth Factor is a Potential Tumor . . . Gliomas In Vivo".
Shweiki et al., Nature 359:843-845 (1992) "Vascular Endothelial Induced by Hypoxia . . . Angiogenesis".
Tischer et al., Journal of Bio. Chem. 266(18) 11947-11954 (1991) "The Human Gene for Vascular . . . Growth Factor".
Gallagher et al., Glycobiology 2(6)523-528 (1992) "Heparan Sulphate in the Binding . . . Growth Factor".
Rapraeger et al. Reports (1991) 1705-1708 "Requirement of Heparan Sulfate . . . Differentiation".
Yayon et al. Cell 64:841-848 (1991) "Cell Surface, Haparin-Like Molecules . . . Receptor".
Oppenheim et al., Annu. Rev. Immunol. 9:617-647 (1991) "Properties of the Novel Proinflammatory Supergene . . . Cytokine Family".
Butcher, Cell 67:1033-1036 (1991) "Leukocyte-Endothelial Cell Recognition: Three (or More) . . . Diversity".
Kjellen et al. Annu. Rev. Biochem 60:443-475 (1991) "Proteoglycans: Structures and Interactions".
Jackson et al., Physio. Review 71(2):481-539 (1991) "Glycosaminoglycans: Molecular Properties, Protein . . . Processes".
Tanaka et al., Immunology Today, 14(3):111-115 (1993) "Proteoglycans on Endothelial Cells Present Adhesion-Inducing . . . Leukocytes".
Kan et al., Science 259:1918-1921 (1993) "An Essential Heparin-Binding Domain in the Fibroblast Growth Factor Receptor Kinase".
Wing et al., "Use of large-scale hydrazinolysis in the preparation of N-of N-linked oligosaccharide libraries: application to brain issue", Glycoconjugate Journal, 9:293-301 (1992).
Mizuochi et al., "A Library of Oligosaccharide Probes (Neoglycolipids) from N-Glycosylated Proteins Reveals That Conglutinin Binds to Certain Complex-type as Well as High Mannose-type Oligosaccharide Chains", The Journal of Biological Chemistry, 264:13834-13839 (1989).
Segarini et al., "The High Molecular Weight Receptor to Transforming Growth Factor-.beta. Contains Glycosaminolgycan Chains," J. Biol. Chem., vol. 263, No. 17, pp. 8366-8370, 1988.
Cheifetz et al., "Transforming Growth Factor-.beta. (TGF-.beta.) Receptor Proteoglycan," J. Biol. Chem., vol. 2664, No. 20, pp. 12025-12028, 1989.
Andres et al., "Binding of Two Growth Factor Families to Separate Domains of the Proteoglycan Betaglycan," vol. 267, No. 9, pp. 5927-5930, 1992.
Cheifetz et al., "The Transforming Growth Factor-.beta. Receptor Type III is a Membrane Proteoglycan," J. Biol. Chem., vol. 263, No. 32, pp. 16984-16991, 1988.
Herlihy, Jr. Walter C.
Witt Daniel P.
Peselev Elli
Repligen Corporation
LandOfFree
Analogs for specific oligosaccharide-protein interactions and us does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analogs for specific oligosaccharide-protein interactions and us, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analogs for specific oligosaccharide-protein interactions and us will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114739